Purple Biotech Ltd ADR (NASDAQ:PPBT) price on Thursday, July 24, fall -4.73% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.62.
A look at the stock’s price movement, the close in the last trading session was $2.75, moving within a range at $2.4712 and $2.73. The beta value (5-Year monthly) was -0.702. Turning to its 52-week performance, $13.95 and $2.00 were the 52-week high and 52-week low respectively. Overall, PPBT moved 12.93% over the past month.
Purple Biotech Ltd ADR’s market cap currently stands at around $7.44 million, with investors looking forward to this quarter’s earnings report slated for on 2024-May-21.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PPBT is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
PPBT’s current price about 4.71% and 6.08% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 55.57, while 7-day volatility ratio is 8.19% and 5.80% in the 30-day chart. Further, Purple Biotech Ltd ADR (PPBT) has a beta value of 0.51.
If we refocus on Purple Biotech Ltd ADR (NASDAQ:PPBT), historical trading data shows that trading volumes averaged 0.48 over the past 10 days and 110.05K over the past 3 months. The company’s latest data on shares outstanding shows there are 2.84 million shares.
The 0.10% of Purple Biotech Ltd ADR’s shares are in the hands of company insiders while institutional holders own 1.94% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.14 million on 2025-06-30, giving us a short ratio of 5.13. The data shows that as of 2025-06-30 short interest in Purple Biotech Ltd ADR (PPBT) stood at 561.0 of shares outstanding, with shares short falling to 0.17 million registered in 2025-05-30. Current price change has pushed the stock -62.68% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PPBT stock continues to rise going into the next quarter.
